Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Hong

Showing results (871-880 of 948) with videos related to

Pageof 95
Sort By:
Nature Communications|January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)Anna Li, Wei-Neng Feng, Juan Li, et al.
Nature Neuroscience|November 18, 2025
Spinal cord Tau pathology induces tactile deficits and cognitive impairment in Alzheimer's disease via dysregulation of CCK neuronsYang Zhou, Wen-Lian Li, Zhi-Qiang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancerQing Zhou, Xu-Chao Zhang, Zhi-Hong Chen, et al.
Liver Cancer|August 6, 2016
Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical TrialsHee Chul Park, Jeong Il Yu, Jason Chia-Hsien Cheng, et al.
Nature Neuroscience|July 1, 2026
Author Correction: Spinal cord Tau pathology induces tactile deficits and cognitive impairment in Alzheimer's disease via dysregulation of CCK neuronsYang Zhou, Wen-Lian Li, Zhi-Qiang Liu, et al.
Thoracic Cancer|April 19, 2022
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp- untreated patients with advanced non-small cell lung cancerKai-Cheng Peng, Jun-Wei Su, Zhi Xie, et al.
Frontiers in Genetics|February 13, 2019
Exome Sequencing Identifies <i>TENM4</i> as a Novel Candidate Gene for Schizophrenia in the SCZD2 Locus at 11q14-21Chao-Biao Xue, Zhou-Heng Xu, Jun Zhu, et al.
Experimental Hematology & Oncology|November 11, 2021
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsLun-Xi Peng, Guang-Ling Jie, An-Na Li, et al.
Oncotarget|November 9, 2016
Association of serum 25-hydroxyvitamin D status with bone mineral density in 0-7 year old childrenYanrong Fu, Youfang Hu, Zhenying Qin, et al.
The Journal of Biological Chemistry|May 31, 2023
m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinomaWei-Hong Zheng, Zhi-Qing Long, Zi-Qi Zheng, et al.
Pageof 95

Showing results (871-880 of 948) with videos related to

Sort By:
Pageof 95
Nature Communications|January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)Anna Li, Wei-Neng Feng, Juan Li, et al.
Nature Neuroscience|November 18, 2025
Spinal cord Tau pathology induces tactile deficits and cognitive impairment in Alzheimer's disease via dysregulation of CCK neuronsYang Zhou, Wen-Lian Li, Zhi-Qiang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancerQing Zhou, Xu-Chao Zhang, Zhi-Hong Chen, et al.
Liver Cancer|August 6, 2016
Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical TrialsHee Chul Park, Jeong Il Yu, Jason Chia-Hsien Cheng, et al.
Nature Neuroscience|July 1, 2026
Author Correction: Spinal cord Tau pathology induces tactile deficits and cognitive impairment in Alzheimer's disease via dysregulation of CCK neuronsYang Zhou, Wen-Lian Li, Zhi-Qiang Liu, et al.
Thoracic Cancer|April 19, 2022
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp- untreated patients with advanced non-small cell lung cancerKai-Cheng Peng, Jun-Wei Su, Zhi Xie, et al.
Frontiers in Genetics|February 13, 2019
Exome Sequencing Identifies <i>TENM4</i> as a Novel Candidate Gene for Schizophrenia in the SCZD2 Locus at 11q14-21Chao-Biao Xue, Zhou-Heng Xu, Jun Zhu, et al.
Experimental Hematology & Oncology|November 11, 2021
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsLun-Xi Peng, Guang-Ling Jie, An-Na Li, et al.
Oncotarget|November 9, 2016
Association of serum 25-hydroxyvitamin D status with bone mineral density in 0-7 year old childrenYanrong Fu, Youfang Hu, Zhenying Qin, et al.
The Journal of Biological Chemistry|May 31, 2023
m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinomaWei-Hong Zheng, Zhi-Qing Long, Zi-Qi Zheng, et al.
Pageof 95